You are here: Industry Insights > brazil

News List

After suspending EUA request, Brazil now shelves import authorisation of Covaxin expresspharma
July 30, 2021
After suspending the proposed clinical trials of Bharat Bioetch’s COVID-19 vaccine Covaxin and a request for Emergency Use Authorisation, Brazil now has suspended its decision to import four million doses of the jab into that country.
Brazil's Anvisa suspends Covaxin shot's emergency use application firstwordpharma
July 01, 2021
Brazil's health regulator has suspended Covaxin's emergency-use application, which was filed by an intermediary on behalf of the COVID-19 vaccine's developer Bharat Biotech, as reported in This is Money.
Brazil’s Anvisa rejects import of Russia’s Covid-19 vaccine pharmaceutical-technology
April 28, 2021
The Brazilian National Health Surveillance Agency (Anvisa) has rejected the import of the Russian Covid-19 vaccine, Sputnik V, citing a lack of consistent and reliable data.
Brazil could approve Russian coronavirus vaccine in days, says pharmaceutical firm expresspharma
March 25, 2021
The Brazilian pharmaceutical company that plans to produce Russia’s coronavirus vaccine Sputnik V said on Tuesday it expects to overcome regulatory obstacles in “two or three” days to obtain authorisation to make and sell the shot in Brazil.
Pfizer COVID-19 vaccine works against Brazil variant in lab study expresspharma
March 09, 2021
The scientists said the neutralising ability was roughly equivalent to the vaccine’s effect on a previous less contagious version of the virus from last year.
Bharat Biotech signs supply deal with Brazil for 20 million doses of COVAXIN expresspharma
March 01, 2021
Bharat Biotech International confirmed that the company has signed an agreement with Brazil for supply of 20 million doses of COVAXIN.
Tiziana’s Foralumab suppresses lung inflammation in Brazil Covid-19 trial pharmaceutical-technology
February 04, 2021
Tiziana Life Sciences has reported positive data from an exploratory clinical study in Brazil evaluating its nasally administered anti-CD3 human monoclonal antibody, Foralumab, in Covid-19 patients.
Clinical Trial of Proxalutamide's Trial of Hospitalized Covid-19 Patients Was Approved in Brazil prnasia
January 29, 2021
Kintor Pharmaceutical Limited is pleased to announce that the clinical trial of Proxalutamide's treatment of hospitalized COVID-19 patients was approved by the Institutional Review Board of Brazil.
Bharat Biotech signs deal with Precisa Medicamentos for COVAXIN supply to Brazil expresspharma
January 13, 2021
Supplies will be prioritised for the public market through a direct procurement by the Government of Brazil, private market will get the vaccine after receipt of market authorisation from ANVISA.
SinoVac gets authorisation to restart Covid-19 vaccine trial in Brazil pharmaceutical-technology
November 12, 2020
Chinese biopharmaceutical firm Sinovac is set to resume the Phase III trial of the Inactivated Covid-19 vaccine, CoronaVaC, after the Brazil National Health Surveillance Agency (Anvisa) authorised its resumption.

Previous page 1 2 3 Next page